K. Börner
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 46
- Antibiotics Pharmacokinetics and Efficacy 45
- Epidemiology 20
- Pneumonia and Respiratory Infections 14
- Co-authors
- P. Koeppe (37 shared papers)H. Lode (38 shared papers)G. Höffken (15 shared papers)H. Lode (8 shared papers)T. Schaberg (6 shared papers)P. Olschewski (6 shared papers)E. A. Rössler (4 shared papers)Hans‐Martin Vieth (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (18 papers)Journal of Antimicrobial Chemotherapy (8 papers)European Journal of Clinical Pharmacology (4 papers)Drugs (4 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
K. Börner
88 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 130
- Molecular Medicine 529
- Pharmacology 1.2k
- Applied Microbiology and Biotechnology 70
- Clinical Biochemistry 135
- Epidemiology 550
Countries citing papers authored by K. Börner
This map shows the geographic impact of K. Börner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Börner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Börner more than expected).
Fields of papers citing papers by K. Börner
This network shows the impact of papers produced by K. Börner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Börner. The network helps show where K. Börner may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Börner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 253 | |
| 2 | 1998 | 195 | |
| 3 | 1987 | 139 | |
| 4 | 1996 | 117 | |
| 5 | 1990 | 97 | |
| 6 | 1986 | 84 | |
| 7 | 1996 | 62 | |
| 8 | 1998 | 52 | |
| 9 | 1981 | 51 | |
| 10 | 1987 | 50 | |
| 11 | 1997 | 45 | |
| 12 | 1983 | 45 | |
| 13 | 1990 | 43 | |
| 14 | 1992 | 43 | |
| 15 | 1988 | 42 | |
| 16 | 1992 | 40 | |
| 17 | 1987 | 38 | |
| 18 | 1993 | 38 | |
| 19 | 1990 | 31 | |
| 20 | 2001 | 30 |
About K. Börner
K. Börner is a scholar working on Pharmacology, Epidemiology, Oncology, Molecular Medicine and Molecular Biology, having authored 92 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (45 papers), Drug Transport and Resistance Mechanisms (17 papers), Antibiotic Resistance in Bacteria (15 papers), Pneumonia and Respiratory Infections (14 papers), Analytical Methods in Pharmaceuticals (10 papers), Epilepsy research and treatment (5 papers), Analytical Chemistry and Chromatography (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Molecular Medicine (529 citations), Pharmacology (1.2k citations), Applied Microbiology and Biotechnology (70 citations), Clinical Biochemistry (135 citations) and Epidemiology (550 citations). K. Börner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include P. Koeppe, H. Lode, G. Höffken, H. Lode, T. Schaberg, P. Olschewski, E. A. Rössler, Hans‐Martin Vieth, Matthias Taupitz and Michael D. Schulz. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Pharmacology, Drugs and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.